Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
GlucoTrack (GCTK)
NASDAQ:GCTK
Holding GCTK?
Track your performance easily
GCTK Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.20 - $4.95
Previous Close$0.29
Volume514.50K
Average Volume (3M)471.67K
Market Cap
$3.56M
Enterprise Value$3.28M
Total Cash (Recent Filing)$346.00K
Total Debt (Recent Filing)$70.00K
Price to Earnings (P/E)―
Beta0.27
Next Earnings
May 15, 2018EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.89
Shares Outstanding5,772,026
10 Day Avg. Volume1,474,813
30 Day Avg. Volume471,673
Standard Deviation0.33
R-Squared0.00008
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)-0.42
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.39
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
GlucoTrack News
PremiumCompany Announcements
GlucoTrack Begins Clinical Study of Implantable Glucose Monitor
PremiumCompany Announcements
GlucoTrack Completes Funding to Enhance Financial Stability
PremiumCompany Announcements
GlucoTrack to Unveil Implantable Glucose Monitor at BioFuture
PremiumCompany Announcements
GlucoTrack Showcases Innovations at Diabetes Tech Meeting
Ownership Overview
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
GCTK FAQ
What was GlucoTrack’s price range in the past 12 months?
GlucoTrack lowest stock price was $0.20 and its highest was $4.95 in the past 12 months.
What is GlucoTrack’s market cap?
Currently, no data Available
When is GlucoTrack’s upcoming earnings report date?
GlucoTrack’s upcoming earnings report date is May 15, 2018 which is 2413 days ago.
How were GlucoTrack’s earnings last quarter?
Currently, no data Available
Is GlucoTrack overvalued?
According to Wall Street analysts GlucoTrack’s price is currently Overvalued.
Does GlucoTrack pay dividends?
GlucoTrack does not currently pay dividends.
What is GlucoTrack’s EPS estimate?
GlucoTrack’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GlucoTrack have?
GlucoTrack has 16,052,172 shares outstanding.
What happened to GlucoTrack’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of GlucoTrack?
Currently, no hedge funds are holding shares in GCTK
---
GlucoTrack Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-75.29%
12-Months-Change
Fundamentals
Return on Equity
-1943.32%
Trailing 12-Months
Asset Growth
-88.52%
Trailing 12-Months
Company Description
GlucoTrack
Integrity Applications, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Ashkelon, Israel.
---
Technical Analysis
---